Robert B. Bhisitkul
About
In The Last Decade
Robert B. Bhisitkul
54 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Ophthalmology 2.6k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Molecular Biology 665
- Cellular and Molecular Neuroscience 195
- Neurology 141
Countries citing papers authored by Robert B. Bhisitkul
This map shows the geographic impact of Robert B. Bhisitkul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Bhisitkul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Bhisitkul more than expected).
Fields of papers citing papers by Robert B. Bhisitkul
This network shows the impact of papers produced by Robert B. Bhisitkul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Bhisitkul. The network helps show where Robert B. Bhisitkul may publish in the future.
Co-authorship network of co-authors of Robert B. Bhisitkul
This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Bhisitkul. A scholar is included among the top collaborators of Robert B. Bhisitkul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Bhisitkul. Robert B. Bhisitkul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 8 | |
| 3 | 4 | |
| 4 | Clinical trial versus real-world outcomes with anti-VEGF therapy for branch and central retinal vein occlusion | 0 |
| 5 | 4 | |
| 6 | 18 | |
| 7 | Evaluation of self-sealing scleral incision integrity in a fluorescein-perfused human cadaver eye model. | 0 |
| 8 | 22 | |
| 9 | 17 | |
| 10 | 43 | |
| 11 | Year 7 Outcomes For Ranibizumab-treated Subjects In Anchor/marina: A Multicenter, Prospective Cohort Study | 1 |
| 12 | 174 | |
| 13 | Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study breakdown → | 376 |
| 14 | Retinal Toxicity Induced by Subretinal vs. Sub–RPE Hemorrhage in a Rabbit Model of Macular Degeneration | 0 |
| 15 | HIF–1–mediated induction of VEGF in RPE cells: upregulation by constitutively active HIF–1 and inhibition by RNA interference | 1 |
| 16 | 12 | |
| 17 | 11 | |
| 18 | 7 | |
| 19 | 53 | |
| 20 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.